These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22138293)

  • 1. [Practical questions around individual with a pacemaker or an implantable cardioverter defibrillator].
    Manaouil C; Fantoni S; Montpellier D; Tordjman E; Jarde O
    Presse Med; 2012 Jul; 41(7-8):736-44. PubMed ID: 22138293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations.
    Rapsang AG; Bhattacharyya P
    Braz J Anesthesiol; 2014; 64(3):205-14. PubMed ID: 24907883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic implantable cardioverter defibrillator. Current status.
    Manolis AS; Rastegar H; Estes NA
    JAMA; 1989 Sep; 262(10):1362-8. PubMed ID: 2668575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferences in the everyday life of the patient with a cardiac pacemaker or an implantable defibrillator].
    Sadoul N; Blangy H; Dodinot B
    Arch Mal Coeur Vaiss; 2003 Apr; 96 Spec No 3():12-21. PubMed ID: 12741327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in patients with implantable cardiac devices.
    Sierra M; Machado C
    Rev Cardiovasc Med; 2008; 9(4):232-8. PubMed ID: 19122581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
    Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
    Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing with pacemakers and implantable cardioverter defibrillators.
    Lampert R
    Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
    [No Abstract]   [Full Text] [Related]  

  • 10. Disturbing uptick in defibrillator recalls. Most pacemakers and implantable cardioverter/defibrillators work as they should, though the number recalled each year is growing.
    Harv Heart Lett; 2005 Dec; 16(4):1-2. PubMed ID: 16437763
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators.
    Seidman SJ; Brockman R; Lewis BM; Guag J; Shein MJ; Clement WJ; Kippola J; Digby D; Barber C; Huntwork D
    Heart Rhythm; 2010 Jan; 7(1):99-107. PubMed ID: 20129290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use.
    Gold MR; Kanal E; Schwitter J; Sommer T; Yoon H; Ellingson M; Landborg L; Bratten T
    Heart Rhythm; 2015 Mar; 12(3):631-638. PubMed ID: 25496984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey.
    Marinskis G; Bongiorni MG; Dagres N; Dobreanu D; Lewalter T; Blomström-Lundqvist C;
    Europace; 2012 Dec; 14(12):1807-9. PubMed ID: 23134623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Imaging in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators.
    Sommer T; Bauer W; Fischbach K; Kolb C; Luechinger R; Wiegand U; Lotz J; Eitel I; Gutberlet M; Thiele H; Schild HH; Kelm M; Quick HH; Schulz-Menger J; Barkhausen J; Bänsch D
    Rofo; 2017 Mar; 189(3):204-217. PubMed ID: 28201839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy in patients with a pacemaker or an implantable cardioverter defibrillator].
    Zaremba T; Thøgersen AM; Jakobsen AR; Hjortshøj SP; Eschen O; Riahi S
    Ugeskr Laeger; 2011 Sep; 173(36):2195-7. PubMed ID: 21893003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
    Sweeney MO
    Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac pacemakers and implantable defibrillators in terminal care.
    Braun TC; Hagen NA; Hatfield RE; Wyse DG
    J Pain Symptom Manage; 1999 Aug; 18(2):126-31. PubMed ID: 10484860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population.
    Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ
    J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.